Statement of Changes in Stockholders’ Equity - 7 months ended Dec. 31, 2020 - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at May. 26, 2020
Balance (in Shares) at May. 26, 2020
Issuance of common stock to Sponsor	$ 863	24,137		25,000
Issuance of common stock to Sponsor (in Shares)	8,625,000
Sale of 31,945,344 Units, net of underwriting discount and offering expenses	$ 3,194	302,637,300		302,640,494
Sale of 31,945,344 Units, net of underwriting discount and offering expenses (in Shares)	31,945,344
Sale of 8,139,069 Private Placement Warrants		8,139,069		8,139,069
Forfeiture of Founder Shares	$ (64)	64
Forfeiture of Founder Shares (in Shares)	(638,664)
Common stock subject to possible redemption	$ (1,554)	(155,474,278)		(155,475,832)
Common stock subject to possible redemption (in Shares)	(15,546,342)
Share-based compensation for warrant liabilities		3,092,846		3,092,846
Initial classification of warrant liability		(32,475,569)		(32,475,569)
Net loss			(120,946,001)	(120,946,001)
Balance at Dec. 31, 2020	$ 2,439	$ 125,943,569	$ (120,946,001)	$ 5,000,007
Balance (in Shares) at Dec. 31, 2020	24,385,338